William E. Fahl
Professor/ Chief Scientific Officer
the University of Wisconsin School of Medicine and Public Health
William E. Fahl is a Professor of Oncology at the University of Wisconsin School of Medicine and Public Health. He is the Chief Scientific Officer of Suzhou NG Biomedicine (http://www.ngbiomedicine.com/), the Company that is currently pursuing clinical trials of topically applied vasoconstrictor to suppress oral mucositis, radiation dermatitis and alopecia in cancer therapy patients. He is also the founder of NG Biomedicine US, Inc. a Madison Wisconsin corporation. Dr. Fahl has published more than 100 scientific papers and has more then 25 issued patents.